BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Enzyme Developer EUCODIS Bioscience Launches Phospholipases


3/9/2010 7:22:29 AM

VIENNA, Austria, March 9, 2010 /PRNewswire/ -- EUCODIS Bioscience, a company providing customized enzymes to the pharmaceutical, chemical, and other industries, announced today that it has launched a panel of phospholipases, adding a new enzyme family to its product portfolio.

Phospholipases are a group of enzymes that are widely used in the industrial processing of natural fats and oils, such as in the food and beverage industries, in the cosmetics industry, and in the manufacturing of bioproducts from renewable resources (biomass). The market for phospholipases is estimated at EUR 40 million.

In 2009, EUCODIS Bioscience has launched several enzyme products, including a library of currently 20 novel lipases and beta-lactamases.

Commenting on the launch of a new product group, Thomas Fischer, CEO of EUCODIS Bioscience, said: "In adding new enzymes to our product portfolio, we continue to execute our customer-focused strategy: We offer novel enzymes with promising properties to a broad range of industries, we manufacture commercial quantities according to market demand, and we engineer enzymes to customers' specific needs. Feedback from the market is an impressive confirmation of this strategy, with our order book filling steadily."

About EUCODIS Bioscience

EUCODIS Bioscience GmbH develops, customizes, manufactures, and markets industrial enzymes.

EUCODIS Bioscience' products help customers in the chemical, pharmaceutical, and food and feed industries to make manufacturing processes more efficient and cleaner, and to generate products with superior properties.

The Company offers a broad portfolio of novel enzymes, including lipases, phospholipases, and beta-lactamases.

Led by an experienced management team, EUCODIS Bioscience is backed by Austrian and German institutional venture capital funds and private investors. The Company is headquartered in Austria, Europe, with a subsidiary in Germany.

CONTACT: Company Contact EUCODIS Bioscience: Thomas Fischer, MBA, CEO,
EUCODIS Bioscience, Campus Vienna Biocenter II, Viehmarktgasse 2 a/ 2. OG,
A-1030 Vienna, AUSTRIA; +43-1-8900804 or +43-676-3650016,
office@eucodisbioscience.com; Media Contact EUCODIS Bioscience: Frank
Butschbacher, Investor Relations & Communications, +43-650-7844940,
office@butschbacher.net



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES